EMBECTA CORP. Proceeds from Sale of Productive Assets
EMBECTA CORP. (EMBC) reported Proceeds from Sale of Productive Assets of $10.10 million for the 9-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Cash Flow › Investing Activities
us-gaap:ProceedsFromSaleOfProductiveAssets · last filed 2026-08-07
- EMBECTA CORP. proceeds from sale of productive assets for the quarter ending 2026-06-30 was $0.00.
- EMBECTA CORP. proceeds from sale of productive assets for the quarter ending 2026-03-31 was $0.00.
- EMBECTA CORP. proceeds from sale of productive assets for the quarter ending 2025-12-31 was $10.10M.
- EMBECTA CORP. proceeds from sale of productive assets for the quarter ending 2025-06-30 was $0.00.
| Period end | Proceeds from Sale of Productive Assets 3 month | Proceeds from Sale of Productive Assets 6 month | Proceeds from Sale of Productive Assets 9 month |
|---|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2026-08-07 | $0.00 derived: sum of 2 quarters · filed 2026-08-07 | $10.10M 10-Q · filed 2026-08-07 |
| 2026-03-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-05-05 | $10.10M 10-Q · filed 2026-05-05 | |
| 2025-12-31 | $10.10M 10-Q · filed 2026-02-05 | ||
| 2025-06-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2026-08-07 | $0.00 derived: sum of 2 quarters · filed 2026-08-07 | $0.00 10-Q · filed 2026-08-07 |
| 2025-03-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-05-05 | $0.00 10-Q · filed 2026-05-05 | |
| 2024-12-31 | $0.00 10-Q · filed 2026-02-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |